Qoraa: Gregory Harris
Taariikhda Abuurista: 10 Abriil 2021
Taariikhda Cusboonaysiinta: 18 Noofeembar 2024
Anonim
L-Триптофан и 5-HTP что это? Как принимать от депрессии, бессонницы и для похудения?
Dareemoleyad: L-Триптофан и 5-HTP что это? Как принимать от депрессии, бессонницы и для похудения?

Qanacsan

5-HTP (5-hydroxytryptophan) waa wax soo saar kiimiko ah oo ka mid ah dhismaha dhismaha borotiinka L-tryptophan. Waxaa sidoo kale ganacsi ahaan laga soo saaray miraha dhir Afrikaan ah oo loo yaqaan 'Griffonia simplicifolia'.

5-HTP waxaa loo isticmaalaa cilladaha hurdada sida hurdo la’aanta, diiqadda, walwalka, iyo xaalado kale oo badan, laakiin ma jiraan caddeyn cilmiya oo wanaagsan oo lagu taageerayo inta badan isticmaalladan.

Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran waxay qiimeysaa waxtarka ku saleysan caddeynta sayniska iyadoo loo eegayo cabirka soo socda: Wax ku ool ah, Suurta gal ah inuu wax ku ool yahay, suurtagal tahay wax ku ool ah, macquul ahaan waxtar la'aan, suurtagal ahaan waxtar la'aan, waxtar la'aan, iyo caddayn ku filan oo lagu qiimeeyo.

Qiimeynta waxtarka ee 5-HTP waa sida soo socota:

Suurtagal inay wax ku ool u tahay ...

  • Niyad jab. Qaadashada 5-HTP ee afka waxay umuuqataa inay wanaajineyso calaamadaha niyadjabka dadka qaar. Qaar ka mid ah cilmi baarista caafimaad waxay muujineysaa in qaadashada 5-HTP ee afka laga qaato ay faa'iido u lahaan karto dawooyinka qaarkood ee daawada lidka ku ah diiqadda ee loogu talagalay hagaajinta calaamadaha niyadjabka. Daraasadaha badankood, 150-800 mg maalintii 5-HTP ayaa laqaatay. Xaaladaha qaarkood, qiyaaso badan ayaa la isticmaalay.

Suurtagal ma ahan waxtar ...

  • Cilladda Down syndrome-ka. Cilmi baarisyada qaarkood waxay muujinayaan in 5-HTP la siiyo dhallaanka qaba cilladda Down syndrome-ka waxaa laga yaabaa inay hagaajiso murqaha iyo dhaqdhaqaaqa. Cilmi-baaris kale waxay muujineysaa inaysan hagaajinaynin muruqyada ama koritaanka marka laga soo bilaabo dhallaanka illaa 3-4 sano jir. Cilmi baarista ayaa sidoo kale muujineysa in qaadashada 5-HTP oo ay weheliso daawooyinka caadiga ee laguu qoro ay hagaajiso horumarka, xirfadaha bulshada, ama xirfadaha luqadeed

Cadeymo aan ku filneyn in lagu qiimeeyo wax ku oolnimada ...

  • Nooc walwal ah oo lagu calaamadeeyay fikradaha soo noqnoqda iyo dabeecadaha soo noqnoqda (cillad qasab ah oo qasab ah ama OCD). Daraasad hore waxay muujisay qaadashada 5-HTP ee dawada lidka diiqadda ee fluoxetine (Prozac) muddo 12 toddobaad ah waxay hagaajin kartaa calaamadaha OCD.
  • Ciladda isticmaalka aalkolada. Cilmibaarista hore waxay muujineysaa in qaadashada 5-HTP ee D-phenylalanine iyo L-glutamine muddo 40 maalmood ah ay yareyn karto astaamaha ka bixitaanka aalkolada. Si kastaba ha noqotee, qaadashada 5-HTP ee leh carbidopa maalin kasta hal sano uma muuqato inay ka caawineyso dadka inay joojiyaan cabitaanka. Saamaynta 5-HTP keliya ee khamriga ma cadda.
  • Cudurka Alzheimer. Cilmi-baarista hore waxay soo jeedineysaa in qaadashada 5-HTP ee afka laga qaato aysan caawinaynin calaamadaha cudurka Alzheimer.
  • Walaac. Caddaymaha ku saabsan saamaynta 5-HTP ee walaaca ma cadda. Cilmi-baarista hore waxay muujineysaa in qaadashada 25-150 mg oo 5-HTP ah maalin kasta oo ay weheliso carbidopa ay u muuqato inay yareyneyso calaamadaha walaaca ee dadka qaba walwalka walaaca. Si kastaba ha noqotee, cilmi baaris kale oo hore waxay muujineysaa in qaadashada qiyaasta sare ee 5-HTP, 225 mg maalin kasta ama in ka badan, ay umuuqato inay walwalka sii xumeyneyso. Sidoo kale, qaadashada 60 mg oo 5-HTP ah maalin kasta iyada oo loo marayo xididka ma yareyneyso walwalka dadka qaba dhibaatooyinka argagaxa.
  • Dhaawaca maskaxda ee saameeya dhaqdhaqaaqa muruqyada (cerebellar ataxia). Caddaynta ku saabsan isticmaalka 5-HTP ee loo yaqaan 'cerebellar ataxia' ma cadda. Caddaynta hore waxay muujineysaa in qaadashada 5 mg / kg ee 5-HTP maalin kasta 4 bilood ay yareyn karto cilladda nidaamka neerfaha. Si kastaba ha noqotee, cilmi baaris kale ayaa muujineysa in qaadashada 5-HTP maalin kasta illaa hal sano aysan hagaajinaynin calaamadaha 'cerebellar ataxia'.
  • Fibromyalgia. Cilmi-baarista hore waxay soo jeedineysaa in qaadashada 100 mg oo 5-HTP ah saddex jeer maalintii seddexaad 30-90 maalmood laga yaabo inay hagaajiso xanuunka, jilicsanaanta, hurdada, walwalka, daalka, iyo adkaanta subaxa dadka qaba fibromyalgia.
  • Calaamadaha dayska. Cilmibaaris hore waxay soo jeedineysaa in qaadashada 150 mg oo 5-HTP ah maalin kasta 4 toddobaad aysan yareynayn dhalaalka kulul ee haweenka postmenopausal.
  • Dhanjaf. Caddaynta ku saabsan saamaynta 5-HTP ee kahortagga ama daaweynta xanuunka dhanjafka ee dadka waaweyn ma cadda. Daraasadaha qaarkood waxay muujinayaan in qaadashada 5-HTP maalin kasta aysan yareynayn xanuunka dhanjafka, halka daraasadaha kale ay muujinayaan inay faa'iido u yeelan karto dawooyinka loo qoro. 5-HTP uma muuqato inuu yareynayo xanuunka dhanjafka ee carruurta.
  • Cayilka. Cilmi-baarista hore waxay soo jeedineysaa in qaadashada 5-HTP ay gacan ka geysan karto yareynta rabitaanka cuntada, qaadashada kalooriga, iyo culeyska dadka cayilan. Cilmi-baaris kale ayaa soo jeedinaysa in la adeegsado buufin afka ah oo gaar ah oo ay ku jiraan 5-HTP iyo waxyaalo kale oo laga soosaaray (5-HTP-Nat Exts, Medestea Biotech Sip, Torino, Italy) muddo 4 toddobaad ah waxay kordhisaa miisaanka oo hoos u dhaca qiyaastii 41% dumarka aadka u buuran ee dhalmada kadib.
  • Ka noqoshada heroin, morphine, iyo daroogooyinka kale ee opioid. Cilmi-baarista hore waxay soo jeedineysaa in qaadashada 200 mg oo 5-HTP ah maalin kasta oo ah 6 maalmood oo ay weheliso tyrosine, fosfatidylcholine, iyo L-glutamine, waxay yareyn kartaa hurdo la’aanta iyo astaamaha ka-noqoshada ee soo kabashada dadka balwada leh ee heroin-ka ah.
  • Cudurka Parkinson. Daraasad hore waxay muujineysaa in qaadashada 100-150 mg 5-HTP ah maalin kasta oo daawooyinka caadiga ah ay umuuqato inay yareynayso ruxitaanka, laakiin faa'iidooyinkaan waxay sii soconayaan oo keliya illaa 5 bilood. Daraasad kale oo hore waxay muujisay in qaadashada 50 mg oo 5-HTP ah maalin kasta ay yareyn karto astaamaha isku-buuqa dhaqdhaqaaqa ee daawada levodopa, iyo sidoo kale calaamadaha niyad-jabka, dadka qaba cudurka Parkinson. Laakiin qaadashada qiyaaso badan oo 5-HTP ah, 275-1500 mg maalin kasta, oo ay weheliso carbidopa ayaa ka sii dari kara calaamadaha qaarkood.
  • Madax xanuun. Cilmi-baarista hore waxay soo jeedineysaa in qaadashada 100 mg oo 5-HTP ah saddex jeer maalintii muddo 8 toddobaad ah aysan yareynaynin xanuunka ama dhererka madax-wareerka kacsan.
  • Feejignaanta maqnaanshaha-jahwareerka (ADHD).
  • Hurdo la'aan.
  • Cudurka dysphoric premenstrual (PMDD).
  • Cudurka premenstrual syndrome (PMS).
  • Ramsey-Hunt syndrome.
  • Xaaladaha kale.
Cadeymo dheeraad ah ayaa loo baahan yahay si loo qiimeeyo waxtarka 5-HTP ee adeegyadan.

5-HTP wuxuu ka shaqeeyaa maskaxda iyo habdhiska neerfaha isaga oo kordhinaya soosaarka kiimikada serotonin. Serotonin wuxuu saameyn ku yeelan karaa hurdada, rabitaanka cuntada, heerkulka, dhaqanka galmada, iyo dareenka xanuunka. Maaddaama 5-HTP ay kordhiso isku-darka serotonin, waxaa loo adeegsadaa dhowr cudur halka serotonin la rumeysan yahay inuu door muhiim ah ka ciyaaro oo ay ka mid yihiin niyadjab, hurdo la'aan, buurnaan, iyo xaalado kale oo badan.

Markii afka lagaa qaado: 5-HTP waa BADBAADO KU SAABSAN markaad afka u qaadanaysid si habboon. Waxaa si badbaado leh loogu isticmaalay qiyaaso ilaa 400 mg maalin kasta illaa hal sano. Laakiin dadka qaarkiis ee qaatay 5-HTP waxay yeesheen xaalad loo yaqaan eosinophilia-myalgia syndrome (EMS). EMS waa xaalad halis ah oo ku lug leh jilicsanaanta muruqyada (myalgia) iyo cilladaha dhiigga (eosinophilia). Dadka qaarkiis waxay u maleynayaan in EMS ay sababi karto walax shil ama wasakheyn ku jirta qaar ka mid ah alaabada 5-HTP. Laakiin ma jiraan caddayn cilmi ku filan oo lagu ogaanayo haddii EMS uu sababo 5-HTP, wasakh, ama arrimo kale. Ilaa inta laga ogaanayo, 5-HTP waa in si taxaddar leh loo adeegsadaa.

Dhibaatooyinka kale ee ka imaan kara 5-HTP waxaa ka mid ah laab xanuun, calool xanuun, lallabbo, matag, shuban, lulmo, dhibaatooyin xagga galmada ah, iyo dhibaatooyin muruqyada ah.

5-HTP waa Suuragal AAN LAHAYN markii afka lagaa qaado qaadasho fara badan. Qiyaasaha laga bilaabo 6-10 garaam maalin kasta ayaa lala xiriiriyay dhibaatooyin daran oo caloosha ah iyo murqo xanuun.

Taxaddarrada gaarka ah & digniinta:

Uurka iyo nuujinta: Ma jiro macluumaad ku filan oo la isku halleyn karo oo lagu ogaanayo haddii 5-HTP ay ammaan tahay in la isticmaalo marka uurka leedahay ama naas nuujinta Joog dhinaca aaminka ah iskana ilaali isticmaalka.

Caruurta: 5-HTP waa BADBAADO KU SAABSAN marka afka si haboon loogu qaato. Qiyaasta ilaa 5 mg / kg maalin kasta ayaa si badbaado leh loo isticmaalay ilaa 3 sano dhallaanka iyo carruurta ilaa 12-sano jirka ah. Sida dadka waaweyn, sidoo kale waxaa jira walaac ku saabsan suurtagalnimada cudurka eosinophilia-myalgia syndrome (EMS) ee carruurta, xaalad halis ah oo ku lug leh jilicsanaan daran (myalgia) iyo cilladaha dhiigga (eosinophilia).

Qalliinka: 5-HTP wuxuu saameyn ku yeelan karaa kiimikada maskaxda loo yaqaan serotonin. Daawooyinka qaarkood ee la qaato inta lagu jiro qalliinka waxay sidoo kale saameyn ku yeelan karaan serotonin. Qaadashada 5-HTP qalliinka ka hor waxay sababi kartaa serotonin aad u fara badan maskaxda waxayna keeni kartaa waxyeelo daran oo ay ka mid yihiin dhibaatooyinka wadnaha, gariir, iyo walaac. U sheeg bukaanka inay joojiyaan qaadashada 5-HTP ugu yaraan 2 toddobaad qalliinka ka hor.

Gaashaanle
Ha qaadan isku-darkaas.
Daawooyinka niyadjabka (MAOIs)
5-HTP wuxuu kordhiyaa kiimiko maskaxda ku jirta oo loo yaqaan serotonin. Daawooyinka qaarkood ee loo isticmaalo niyad-jabka sidoo kale waxay kordhiyaan serotonin. Qaadashada 5-HTP ee daawooyinkan loo isticmaalo niyad-jabka ayaa kordhin kara serotonin aad u badan. Tani waxay sababi kartaa waxyeelo daran oo ay ka mid yihiin madax xanuun daran, dhibaatooyin wadnaha ah, gariir, wareer, iyo walaac.

Qaar ka mid ah daawooyinka loo isticmaalo niyad-jabka waxaa ka mid ah phenelzine (Nardil), tranylcypromine (Parnate), iyo kuwo kale.
Dhexdhexaad
Ka taxaddar isku-dhafkan.
Carbidopa (Lodosyn)
5-HTP wuxuu saameyn ku yeelan karaa maskaxda. Carbidopa (Lodosyn) sidoo kale waxay saameyn ku yeelan kartaa maskaxda. Qaadashada 5-HTP oo ay weheliso carbidopa waxay kordhin kartaa halista waxyeellooyinka halista ah oo ay ku jiraan hadalka degdegga ah, welwelka, gardarrada, iyo kuwa kale.
Daawooyinka daweynta (CNS depressants)
5-HTP waxay sababi kartaa hurdo iyo lulmo. Daawooyinka keena hurdada waxaa loo yaqaan seddexyaal. Qaadashada 5-HTP oo ay weheliso daawooyinka suuxinta waxay sababi kartaa hurdo badan.

Daawooyinka daweynta lihi qaarkood waxaa ka mid ah clonazepam (Klonopin), lorazepam (Ativan), phenobarbital (Donnatal), zolpidem (Ambien), iyo kuwo kale.
Dawooyinka Serotonergic
5-HTP waxay kordhin kartaa kiimiko maskaxda ku jirta oo la yiraahdo serotonin. Daawooyinka qaarkood waxay kaloo kordhiyaan serotonin. Qaadashada 5-HTP oo ay weheliso daawooyinkan waxay kordhin kartaa serotonin aad u badan. Tani waxay sababi kartaa waxyeelo daran oo ay ka mid yihiin madax xanuun daran, dhibaatooyin wadnaha ah, gariir, wareer, iyo walaac.

Daawooyinkaan qaarkood waxaa kamid ah fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft), amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Tofranil), sumatriptan (Imitrex), zolmitriptan (Zomig), rizatriptan (Maxz) methadone (Dolophine), tramadol (Ultram), iyo kuwa kale oo badan.
Dhirta iyo kaabayaasha leh astaamaha daweynta
5-HTP wuxuu sababi karaa hurdo ama lulmo. U isticmaalkeeda iyada oo ay weheliyaan geedo kale iyo waxyaabo dheeri ah oo isku saameyn ah waxay sababi kartaa hurdo badan. Qaar ka mid ah dhirtaas iyo kaabayaashaas waxaa ka mid ah calamus, California poppy, catnip, hops, Jamaican dogwood, kava, St. John’s wort, skullcap, valerian, yerba mansa, iyo kuwo kale.
Dhirta iyo kaabayaasha leh astaamaha serotonergic
5-HTP wuxuu kordhiyaa kiimikada maskaxda loo yaqaan serotonin. Qaadashada 5-HTP oo ay weheliso geedo kale iyo waxyaabo dheeri ah oo kordhiya serotonin waxay u horseedi kartaa serotonin aad u badan waxayna sababi kartaa waxyeelo ay ka mid yihiin dhibaatooyinka wadnaha, gariir iyo walaac. Dhirta kale iyo kaabisyada kordhiya heerarka serotonin waxaa ka mid ah Hawaiian baby woodrose, L-tryptophan, S-adenosylmethionine (SAMe), iyo St. John’s wort.
Ma jiraan wax la yaqaan oo la falgala cunnooyinka.
Qiyaasaha soo socda ayaa lagu bartay cilmi baarista sayniska: DADKA WAAWEYN

Afka:
  • Niyad jab: Inta badan, 150-800 mg maalintii ayaa la qaataa 2-6 toddobaad. Qiyaastaas ayaa mararka qaarkood loo qaybiyaa loona qaataa 50 mg ilaa 100 mg saddex jeer maalintii. Mararka qaarkood qiyaasta waxay kubilaabtaa si hoose oo si isdabajoog ah ayey usii kordhaa 1-2 usbuuc kasta ilaa qiyaasta bartilmaameed laga gaaro Caadi ahaan, qiyaaso badan ayaa la isticmaalaa. Hal daraasad, qiyaasta ayaa si isdaba joog ah loogu kordhiyaa ilaa 3 garaam maalintii.
2-Aamino-3- (5-Hydroxy-1H-Indol-3-yl) Propanoic Acid, 5 Hydroxy-Tryptophan, 5 Hydroxy-Tryptophane, 5-Hydroxytryptophan, 5-Hydroxytryptophane, 5-Hydroxy L-Tryptophan, 5-Hydroxy L-Tryptophane, 5-Hydroxy Tryptophan, 5-L-Hydroxytryptophan, L-5 HTP, L-5-Hydroxytryptophan, L-5-Hydroxytryptophane, Oxitriptan.

Si aad wax badan uga ogaato sida maqaalkan loo qoray, fadlan eeg Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran habka.


  1. Meloni M, Puligheddu M, Sanna F, et al. Wax ku oolnimada iyo badbaadada 5-Hydroxytryptophan oo ku saabsan levodopa-ku-soo-boodka dhaqdhaqaaqa ee cudurka Parkinson: Raadin hordhac ah. J Neurol Sci. 2020; 415: 116869. Eeg aragti
  2. Yousefzadeh F, Sahebolzamani E, Sadri A, iyo al. 5-Hydroxytryptophan oo ah daaweyn loo yaqaan 'adjuvant therapy' oo lagu daaweynayo khalkhal-qasab qasab ah oo dhexdhexaad ah ama daran: tijaabin laba-indho la 'oo la kala soocay oo lagu xakameynayo xakamaynta placebo. Int Clin Psychopharmacol. 2020; 35: 254-262. Eeg aragti
  3. Javelle F, Lampit A, Bloch W, Häussermann P, Johnson SL, Zimmer P. Saamaynta 5-hydroxytryptophan oo ku saabsan noocyada kala duwan ee niyad-jabka: dib-u-eegis nidaamsan iyo falanqayn meta ah. Nutr Rev 2020; 78: 77-88. Eeg aragti
  4. Meloni M, Puligheddu M, Carta M, Cannas A, Figorilli M, Defazio G. Waxtarka iyo badbaadada 5-hydroxytryptophan ee niyadjabka iyo arxandarada cudurka Parkinson: helitaan hordhac ah. Eur J Neurol 2020; 27: 779-786. Eeg aragti
  5. Israelyan N, Del Colle A, Li Z, et al. Saamaynta Serotonin iyo Gaabis-Sii-dayn 5-Hydroxytryptophan ah oo ku saabsan Dhaq-dhaqaaqa Mindhicirka ee Mouse Model of Depression. Gastroenterology. 2019; 157: 507-521.e4. Eeg aragti
  6. Michelson D, Bogga SW, Casey R, iyo al. Cilad la xiriirta eosinophilia-myaligia syndrome oo la xiriirta soo-gaadhista l-5-hydroxytryptophan. J Rheumatol 1994; 21: 2261-5. Eeg aragti
  7. Lemaire PA, Adosraku RK. H HCC habka loogu talagalay baaritaanka tooska ah ee serotonin precursor, 5-hydroxytrophan, abuurka Griffonia simplicifolia. Phytochem dabada 2002; 13: 333-7.
  8. Rondanelli M, Opizzi A, Faliva M, Bucci M, Perna S. Xiriirka udhaxeeya nuugista 5-hydroxytryptophan ee cuntada isku dhafan, iyadoo loo adeegsanayo soosaarida Griffonia simplicifolia, iyo saameynta kudhaca dheddigga miisaanka culus kadib maamulka buufinta afka. Cun Culeyska Miisaanka 2012; 17: e22-8. Eeg aragti
  9. Pardo JV. Mania ka dib marka lagu daro hydroxytryptophan oo loo yaqaan 'monoamine oxidase inhibitor'. Gen Hosp maskaxda 2012; 34: 102.e13-4.
  10. Chen D, Liu Y, He W, Wang H, Wang Z. Neurotransmitter-precursor-supplement intervention for disetoxified heroin addicts. (Chen D, Liu Y, He W, Wang H, Wang Z. Neurotransmitter-precursor-supplement intervention for Detoxified heroin addicts): Chen D, Liu Y, He W, Wang H, Wang Z. Dhexdhexaadinta neurotransmitter-horudhaca-dheellitirka J Huazhong Univ Sci Technologiga Med Sci 2012; 32: 422-7.
  11. Gendle MH, Young EL, Romano AC. Saamaynta afka 5-hydroxytryptophan ee hawsha qorshaynta jaangooyada ah: aragti ku saabsan suurtagalnimada isdhexgalka dopamine / serotonin ee maskaxda hore. Hum Psychopharmacol 2013; 28: 270-3.
  12. Kulamada Guddiga La-talinta ee Farmashiyaha Maamulka Cuntada iyo Dawooyinka ee Mareykanka kulankoodii Juun 17-18, 2015. Waxaa laga heli karaa: www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/pharmacycompoundingadvisorycommittee/ucm455276.pdf (waxaa laga helay 8/21/15).
  13. Maamulka Cuntada iyo Dawooyinka ee Mareykanka. Magacaabista daroogada agoonta iyo oggolaanshaha. Waxaa laga heli karaa: www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm (la helay 8/20/2015).
  14. Das YT, Bagchi M, Bagchi D, Preuss HG. Badbaadada 5-hydroxy-L-tryptophan. Toxicol Lett 2004; 150: 111-22. Eeg aragti
  15. Weise P, Koch R, Shaw KN, Rosenfeld MJ. Isticmaalka 5-HTP ee daaweynta cudurka Down’s syndrome. Dhakhaatiirta carruurta 1974; 54165-8. Eeg aragti
  16. Bazelon M, Paine RS, Cowie VA, et al. Dib-u-celinta hypotonia ee dhallaanka qaba cilladda Down’s syndrome ee maamulka 5-hydroxytryptophan. Lancet 1967; 1: 1130-3. Eeg aragti
  17. Sano I. Daaweynta niyadjabka ee L-5-hydroxytryptophan (L-5-HTP). Maskaxda iyo Neurologia Japonicas 1972; 74: 584.
  18. Klein P, Lees A, iyo Stern G. Cawaaqib xumada 5-hydroxytryptophan ee joogtada ah ee xasiloonida Parkinsonian ee socodka iyo isu dheelitirka iyo cudurada kale ee neerfaha. Adv Neurol 1986; 45: 603-604.
  19. VanPraag, H. M. iyo Korf, J. 5-Hydroxytryptophan oo ah antidepressant: Qiimaha saadaalinta ee tijaabada probenecid. Psychopharmacol.Bull. 1972; 8: 34-35.
  20. Sicuteri F. 5-hydroxytryptophan ee kahortaga dhanjafka. Isgaarsiinta Cilmi-baarista Farmashiyaha 1972; 4: 213-218.
  21. Rosano Burgio, F., Borgatti, R., Scarabello, E., iyo Lanzi, G. Madax xanuun ku dhaca carruurta iyo dhalinyarada. Talaabooyinka Dood-cilmiyeedkii ugu horreeyay ee caalami ah ee madax-xanuun ee carruurta iyo dhallinyarada. 1989; 339-47.
  22. Mathew NT. 5-hydroxytryptophan oo ku jira kahortaga xanuunka dhanjafka: daraasad laba-indhoole ah. Madax xanuun 1978; 18: 111.
  23. De Benedittis G, Massei R. 5-HT horudhac ah prophylaxis xanuunka dhanjafka: daraasad laba-indhoole ah oo iskutallaab ah oo lala socdo L-5-hydroxytryptophan. Clin J Xanuun 1986; 2: 123-129.
  24. Wyatt, R. J., Vaughan, T., Kaplan, J., Galanter, M., iyo Green, R. 5-Hydroxytryptophan iyo schizophrenia daba dheeraatay. Gudaha: Barchas J iyo Usdin E. Serotonin iyo Habdhaqan. New York: Saxaafadda Acedemic; 1973.
  25. Brodie HKH, Sack R, iyo Siever L. Daraasadaha caafimaadka ee L-5-hydroxytryptophan ee niyadjabka. Gudaha: Barchas J iyo Usdin E. Serotonin iyo dabeecad. New York: Saxaafadda Tacliinta; 1973.
  26. Auffret, M., Comte, H., iyo Bene, J. Eosinophilia-myalgia syndrome oo ay sababtay L-5 hydroxytryptophane: ilaa seddex kiis. Fund Clinic Pharmacol 2013; Qalabka 1: waraaqaha P2-204.
  27. Cangiano C, Laviano A, Del Ben M, iyo al. Saamaynta afka 5-hydroxy-tryptophan ee qaadashada tamarta iyo xulashada nafaqeeyayaalka yar yar ee bukaanka sonkorowga aan ku-tiirsaneyn insulin-ta. Int J Obes Relat Metab Dhibaatada 1998; 22: 648-54. Eeg aragti
  28. Ju, C. Y. iyo Tsai, C. T. Serotonergic farsamooyinka ku lug leh xakamaynta quudinta 5-HTP ee jiirka. Chin J Physiol 1995; 38: 235-240. Eeg aragti
  29. Pranzatelli, M. R., Tate, E., Galvan, I., iyo Wheeler, A. Maxkamad la kantaroolay oo 5-hydroxy-L-tryptophan ah oo loogu talagalay ataxia ee suuxdinta myoclonus. Clin Neurol. Neurosurg. 1996; 98: 161-164. Eeg aragti
  30. Frith, C. D., Johnston, E. C., Joseph, M. H., Powell, R.J, iyo Watts, R. W. Tijaabin laba-indho la 'oo 5-hydroxytryptophan ah oo ku saabsan xaalad Lesch-Nyhan syndrome. J Neurol Neurosurg. Cilmu-nafsiga 1976; 39: 656-662. Eeg aragti
  31. Bastard, J., Truelle, J. L., iyo Emile, J. [Waxtarka 5 hydroxy-tryptophan ee cudurka Parkinson]. Nouv Presse Med 9-11-1976; 5: 1836-1837. Eeg aragti
  32. Trouillas P, Serratrice G, Laplane D, iyo al. Foomka Levorotatory ee 5-hydroxytryptophan oo ku yaal atakia Friedreich. Natiijooyinka daraasad wadashaqeyn-laba-indho-indhoole ah. Qalabka Neurol 1995; 52: 456-60. Eeg aragti
  33. Wessel K, Hermsdörfer J, Deger K, iyo al. Daraasad laba-indho-indho-indhayn ah oo leh foomka levorotatory ee hydroxytryptophan ee bukaannada qaba cudurrada maskaxda ku dhaca ee xumaada. Arch Neurol 1995; 52: 451-5. Eeg aragti
  34. Alino, J. J., Gutierrez, J. L., iyo Iglesias, M. L. 5-Hydroxytryptophan (5-HTP) iyo MAOI (nialamide) ee daaweynta niyadjabka. Daraasad laba-indho-indhayn ah. Cudurka Farmashiyada ee 1976; 11: 8-15. Eeg aragti
  35. Pranzatelli, M. R., Tate, E., Huang, Y., Haas, R. H., Bodensteiner, J., Ashwal, S., iyo Franz, D. Neuropharmacology ee suuxdinta myoclonus ee horumarka leh: jawaab celinta 5- hydroxy-L-tryptophan. Suuxdin 1995; 36: 783-791. Eeg aragti
  36. Thomson, J., Rankin, H., Ashcroft, GW, Yates, CM, McQueen, JK, iyo Cummings, SW Daaweynta niyadjabka ee ku dhaqanka guud: isbarbardhiga L-tryptophan, amitriptyline, iyo isku darka L-tryptophan iyo amitriptyline oo leh placebo. Cilmu-nafsiga Med 1982; 12: 741-751. Eeg aragti
  37. Trouillas, P., Garde, A., Robert, JM, Renaud, B., Adeleine, P., Bard, J., iyo Brudon, F. [Dib u soo celinta maskaxda maskaxda ee hoos timaadda maamulka muddada-dheer ee 5-HTP ama isku darka 5-HTP iyo benserazide. 26 kiis oo la tiriyay lana daaweeyay iyadoo la adeegsanayo habab kombuyuutar]. Rev Neurol. (Paris) 1982; 138: 415-435. Eeg aragti
  38. Thal, L. J., Sharpless, N. S., Wolfson, L., iyo Katzman, R. Daaweynta myoclonus oo leh L-5-hydroxytryptophan iyo carbidopa: daaweynta, elektrofisiolojiyada, iyo baaritaanka bayoolaji. Ann Neurol 1980; 7: 570-576. Eeg aragti
  39. van Hiele LJ. l-5-Hydroxytryptophan ee niyad-jabka: daaweynta ugu horeysa ee bedelka maskaxda? Daaweynta 99-ka bukaan-socod ee leh niyad-jabka ‘u adkaysta daaweynta’. Neuropsychobiology 1980; 6: 230-40. Eeg aragti
  40. Magnussen, I.iyo Nielsen-Kudsk, F. Bioavailability iyo dawooyinka laxiriira dawooyinka ee nin afka looga qaato L-5-hydroxytryptophan ee xaalad joogto ah. Acta Pharmacol Toxicol. (Copenh) 1980; 46: 257-262. Eeg aragti
  41. Trouillas, P., Garde, A., Robert, J. M., iyo Adeleine, P. [Dib-u-celinta maskaxda maskaxda ee bini-aadamka ee maamulka muddada-dheer ee 5-hydroxytryptophan]. CR Sances Saadda Sci III 1-5-1981; 292: 119-122. Eeg aragti
  42. Pueschel SM, Reed RB, Cronk CE, Goldstein BI. 5-hydroxytryptophan iyo pyridoxine. Saameyntooda carruurta yaryar ee qaba cudurka Down’s syndrome. Am J Dis Ilmaha 1980; 134: 838-44. Eeg aragti
  43. Longo G, Rudoi I, Iannuccelli M, Strinati R, Panizon F. [Daaweynta madax xanuunka aasaasiga ah ee da'da koritaanka ee L-5-HTP (iskudhaaf ka badan daraasad laba-indho la 'iyo placebo)]. Pediatr Med Chir 1984; 6: 241-5. Eeg aragti
  44. Bono, G., Micieli, G., Sances, G., Calvani, M., iyo Nappi, daaweynta G. L-5HTP ee madax xanuunka aasaasiga ah: isku day lagu aqoonsanayo bukaan socodka. Cephalalgia 1984; 4: 159-165. Eeg aragti
  45. Quadbeck, H., Lehmann, E., iyo Tegeler, J. Isbarbardhiga ficilka lidka diiqada ee tryptophan, tryptophan / 5- hydroxytryptophan isku darka iyo nomifensine. Neuropsychobiology 1984; 11: 111-115. Eeg aragti
  46. van Praag, H. M. Raadinta qaabka ficil ee daawada niyadjabka: 5-HTP / isku darka tyrosine ee niyadjabka. Adv Biochem Psychopharmacol. 1984; 39: 301-314. Eeg aragti
  47. Trouillas P. Xakamaynta cudurka 'cerebellar syndrome' oo leh maamul muddo dheer ah oo 5-HTP ah ama isku darka 5-HTP-benserazide: 21 xaaladood oo leh astaamo tirakooban oo uu kumbuyuutar ku shaqeynayo. Ital J Neurol Sci 1984; 5: 253-266. Eeg aragti
  48. van Praag, H. M. iyo de Haan, S. Chemoprophylaxis ee niyadjabka. Isku day ah in la isbarbar dhigo lithium iyo 5- hydroxytryptophan. Acta Maskax ahaaneed. Qalabka Iskuduwaha 1981; 290: 191-201. Eeg aragti
  49. van Praag, H. iyo de Hann, S. Nuglaanta diiqadda iyo 5-hydroxytryptophan prophylaxis. Maskaxda Maskaxda. 1980; 3: 75-83. Eeg aragti
  50. Soulairac, A. [Tallaabada Hypnotic ee mecloqualone. Isbarbardhiga saameynta placebo iyo secobarbital]. Presse Med 4-10-1971; 79: 817-818. Eeg aragti
  51. Chase, T. N., Ng, L. K., iyo Watanabe, cudurka A. M. Parkinson. Wax ka beddelka 5-hydroxytryptophan. Neerfaha 1972; 22: 479-484. Eeg aragti
  52. Wyatt, R. J., Vaughan, T., Galanter, M., Kaplan, J., iyo Green, R. Isbedelada habdhaqanka ee bukaanada dhimirka ee schizophrenic ee la siiyay L-5- hydroxytryptophan. Sayniska 9-22-1972; 177: 1124-1126. Eeg aragti
  53. van Praag HM, Korf J, Dols LC, Schut T. Daraasad tijaabo ah oo ku saabsan qiimaha saadaalinta ee tijaabada probenecid ee isticmaalka 5-hydroxytryptophan oo ah antidepressant. Cilmu-nafsiga 1972; 25: 14-21. Eeg aragti
  54. Zarcone, V., Kales, A., Scharf, M., Tan, T. L., Simmons, J. Q., iyo Dement, W. C. Soo noqnoqoshada afka ee 5-hydroxytryptophan. Saamaynta habdhaqanka iyo hababka hurdada ee laba carruur ah oo schizophrenic ah. Dhakhtarka maskaxda ee maskaxda 1973; 28: 843-846. Eeg aragti
  55. Chadwick, D., Hallett, M., Harris, R., Jenner, P., Reynolds, EH, iyo Marsden, CD Clinical, biochemical, iyo muuqaalada jireed ee kala soocaya myoclonus ka jawaabaya 5-hydroxytryptophan, tryptophan oo leh monoamine oxidase inhibitor, iyo clonazepam. Maskaxda 1977; 100: 455-487. Eeg aragti
  56. Van Woert, M. H., Rosenbaum, D., Howieson, J., iyo Bowers, M. B., Jr. Daaweynta muddada dheer ee myoclonus iyo xanuunada kale ee neerfaha ee leh L-5- hydroxytryptophan iyo carbidopa. N Engl J Med 1-13-1977; 296: 70-75. Eeg aragti
  57. Nolen WA, van de Putte JJ, Dijken WA, Kamp JS. L-5HTP ee niyadjabka u adkaysta dib-u-qabashada ka hortagayaasha. Daraasad isbarbardhiga furan oo leh tranylcypromine. Br Maskaxda 1985; 147: 16-22. Eeg aragti
  58. De Benedittis G, Massei R. Serotonin horudhaca madax xanuunka asaasiga ah ee joogtada ah. Daraasad laba-indhoole ah oo iskutallaab ah oo lala socdo L-5-hydroxytryptophan iyo placebo. J Neurosurg Sci 1985; 29: 239-48. Eeg aragti
  59. Titus F, Dávalos A, Alom J, Codina A. 5-Hydroxytryptophan iyo methysergide oo ku jira prophylaxis-ka dhanjafka. Maxkamad caafimaad oo kala sooc ah. Eur Neurol 1986; 25: 327-9. Eeg aragti
  60. Santucci M, Cortelli P, Rossi PG, Baruzzi A, Sacquegna T. L-5-hydroxytryptophan iyo placebo ee kahortagga dhanjafka carruurnimada: daraasad laba-indhoole ah oo iskudhafan. Cephalalgia 1986; 6: 155-7. Eeg aragti
  61. Irwin, M. R., Marder, S. R., Fuentenebro, F., iyo Yuwiler, A. L-5-hydroxytryptophan waxay yareeyaan astaamaha maskaxda ee wanaagsan ee ay keento D-amphetamine. Maskaxda Maskaxda. 1987; 22: 283-289. Eeg aragti
  62. Angst J, Woggon B, Schoepf J. Daaweynta niyad-jabka L-5-hydroxytryptophan iyo imipramine. Natiijooyinka laba furan iyo mid daraasad laba-indhoole ah. Dhakhtarka maskaxda Nervenkr 1977; 224: 175-86. Eeg aragti
  63. Kahn RS, Westenberg HG, Verhoeven WM, iyo al. Saameynta horudhaca serotonin iyo qaadashada ka-hortagga dhibaatooyinka walaaca; isbarbar dhig laba-indhoole ah 5-hydroxytryptophan, clomipramine iyo placebo. Int Clin Psychopharmacol 1987; 21: 33-45. Eeg aragti
  64. De Giorgis G, Miletto R, Iannuccelli M, Camuffo M, Scerni S. Madax xanuunka oo lala xiriiriyo hurdo la'aanta carruurta: qiimeynta cilmu-nafsiga iyo daraasadda daaweynta ee la kantaroolay - L-5-HTP iyo placebo. Daawooyinka Exp Clin Res 1987; 13: 425-33. Eeg aragti
  65. Zmilacher, K., Battegay, R., iyo Gastpar, M. L-5-hydroxytryptophan oo keli ah iyo isku-darka xakamaynta xakamaynta decarboxylase ee daaweynta niyad-jabka. Neuropsychobiology 1988; 20: 28-35. Eeg aragti
  66. Nolen, W. A., van de Putte, J. J., Dijken, W. A., Kamp, J. S., Blansjaar, B. A., Kramer, H. J., iyo Haffmans, J. Istaraatiijiyada daaweynta ee niyad-jabka. II. MAO ka-hortagayaasha niyad-jabka u adkaysta antidepressants-ka wareega: laba daraasadood oo iskudhafan oo la xakameynayo oo leh tranylcypromine iyo L-5-hydroxytryptophan iyo nomifensine. Acta maskaxda. Scand 1988; 78: 676-683. Eeg aragti
  67. Kaneko M, Kumashiro H, Takahashi Y, Hoshino Y. L-5HTP daaweynta iyo heerka 5-HT serum ka dib markii L-5-HTP lagu rakibo bukaanka niyadjabsan. Neuropsychobiology 1979; 5: 232-40. Eeg aragti
  68. Rousseau JJ. Saamaynta isku darka levo-5-hydroxytryptophan-dihydroergocristine ee niyadjabka iyo waxqabadka neuropsychic: tijaabo bukaan socod eegto oo laba-indho-indheyn ah oo lagu xakameeyo bukaanada waayeelka ah. Clin Ther 1987; 9: 267-72. Eeg aragti
  69. Anders, T. F., Cann, H. M., Ciaranello, R. D., Barchas, J. D., iyo Berger, P. A. U fiirsasho dheeri ah oo ku saabsan isticmaalka 5-hydroxytryptophan ee cunug qaba cudurka Lesch-Nyhan. Neuropadiatrie. 1978; 9: 157-166. Eeg aragti
  70. Ceci F, Cangiano C, Cairella M, iyo al. Saamaynta maamulka 5-hydroxytryptophan ee afka ku leh dabeecadda quudinta ee maadooyinka dumarka waaweyn ee buuran. J Nuurada Transm 1989; 76: 109-17. Eeg aragti
  71. Jangid P, Malik P, Singh P, Sharma M, Gulia AK. Daraasad isbarbardhig ah oo ku saabsan waxtarka l-5-hydroxytryptophan iyo fluoxetine ee bukaannada soo bandhigaya qaybta ugu horreysa ee niyadjabka. Aasiya J Maskaxda 2013; 6: 29-34. Eeg aragti
  72. Zarcone, V. P., Jr. iyo Hoddes, E. Saamaynta 5-hydroxytryptophan oo ku saabsan kala qaybsanaanta REM ee khamriga. Am J Maskaxiyan 1975; 132: 74-76. Eeg aragti
  73. Opladen, T., Hoffmann, G. F., iyo Blau, N. Daraasad caalami ah oo ku saabsan bukaanada qaba cilladaha tetrahydrobiopterin ee soo bandhigaya hyperphenylalaninaemia. J Dhaxal. Met Dis Dis 2012; 35: 963-973. Eeg aragti
  74. Baraldi, S., Hepgul, N., Mondelli, V., iyo Pariante, C. M. Daaweynta calaamadaha cudurka ee interferon-alpha-kufudud ee cagaarshowga C: dib u eegis nidaamsan. J Clin Psychopharmacol. 2012; 32: 531-543. Eeg aragti
  75. Pan, L., McKain, BW, Madan-Khetarpal, S., Mcguire, M., Diler, RS, Perel, JM, Vockley, J., iyo Brent, DA GTP-cyclohydrolase yaraanta ka jawaabeysa sapropterin iyo kaabista 5-HTP : gargaaridda niyad-jabka daweynta iyo dabeecadda is-dilka. BMJ Kiiska .Rep. 2011; 2011 Eeg aragti aan caadi ahayn.
  76. Friedman, J., Roze, E., Abdenur, JE, Chang, R., Gasperini, S., Saletti, V., Wali, GM, Eiroa, H., Neville, B., Felice, A., Parascandalo, R., Zafeiriou, DI, Arrabal-Fernandez, L., Dill, P., Eichler, FS, Echenne, B., Gutierrez-Solana, LG, Hoffmann, GF, Hyland, K., Kusmierska, K., Tijssen, MA, Lutz, T., Mazzuca, M., Penzien, J., Poll-The BT, Sykut-Cegielska, J., Szymanska, K., Thony, B., iyo Blau, N. Sepiapterin yaraanta yaraanta: waa la daaweyn karaa jilicsanaan maskaxeed. Ann Neurol. 2012; 71: 520-530. Eeg aragti
  77. Jukic T, Rojc B, Boben-Bardutzky D, Hafner M, Ihan A. Isticmaalka kaabista cuntada ee D-phenylalanine, L-glutamine iyo L-5-hydroxytriptophan ee yareynta astaamaha ka bixitaanka aalkolada. Coll Antropol 2011; 35: 1225-30. Eeg aragti
  78. Sarris, J. Niyad-jabka bukaan-eegtada: tusaalaha ku-saleysan is-dhexgalka isku-dhafan ee daaweynta daaweynta. Beddelkeedana. Caafimaadka Med. 2011; 17: 26-37. Eeg aragti
  79. Dill, P., Wagner, M., Somerville, A., Thony, B., Blau, N., iyo Weber, P. Cudurrada neerfaha ee carruurta: adkeysiga paroxysmal, kor u eegida, iyo hypotonia: astaamaha lagu garto yaraanta sepiapterin yaraynta. Neerfaha 1-31-2012; 78: e29-e32. Eeg aragti
  80. Horvath, GA, Selby, K., Poskitt, K., Hyland, K., Waters, PJ, Coulter-Mackie, M., and Stockler-Ipsiroglu, SG Hemiplegic migraine, suuxdinno, isbadbadal ku dhaca isbadalka spastic, xaalad jahwareer, iyo kooma walaalaha qaba serotonin nidaamsan. Cephalalgia 2011; 31: 1580-1586. Eeg aragti
  81. Morrison, K. E. Jadwalka genome oo dhan wuxuu wargaliyaa daaweynta: daawada gaarka loo leeyahay waxay qaadaysaa talaabo kale oo horay loo qaaday. Clin Chem 2011; 57: 1638-1640. Eeg aragti
  82. Bainbridge, MN, Wiszniewski, W., Murdock, DR, Friedman, J., Gonzaga-Jauregui, C., Newsham, I., Reid, JG, Fink, JK, Morgan, MB, Gingras, MC, Muzny, DM, Hoang, LD, Yousaf, S., Lupski, JR, iyo Gibbs, RA Isku xidhka genome oo dhan ee maaraynta bukaanka. Sci Transl.Med 6-15-2011; 3: 87re3. Eeg aragti
  83. den Boer JA, Westenberg HG. Dabeecadda, neuroendocrine, iyo saameynta bayoolaji ee maamulka 5-hydroxytryptophan ee khalkhalka argagaxa. Maskaxda Maskaxda 1990; 31: 267-78. Eeg aragti
  84. Adamsen, D., Meili, D., Blau, N., Thony, B., iyo Ramaekers, V. Autism laxiriira 5-hydroxyindolacetic acid hooseeya ee CSF iyo hiddo-wadaha heterozygous SLC6A4 ee Gly56Ala oo lagu daray 5-HTTLPR L / L noocyada dhiirrigeliyeyaasha . Mol.Genet. Metab 2011; 102: 368-373. Eeg aragti
  85. Cross, D. R., Kellermann, G., McKenzie, L. B., Purvis, K. B., Hill, G. J., iyo Huisman, H. Daaweyn amino acid dabiici ah oo la bartilmaameedsaday oo leh dabeecado khatar ku ah carruurta la korsaday. Daryeelka Carruurta Caafimaadka Dev. 2011; 37: 671-678. Eeg aragti
  86. Gendle, M. H. iyo Golding, A. C. Maamulka afka ee 5-hydroxytryptophan (5-HTP) wuxuu wax u dhimayaa go'aan gaarista iyadoo mugdi ku jiro laakiin aan qatar ku jirin: cadeyn ka timid Hawsha Khamaarka ee Iowa. Hum Psychopharmacol. 2010; 25: 491-499. Eeg aragti
  87. Iovieno, N., Dalton, E. D., Fava, M., iyo Mischoulon, D. Dawooyinka lidka ku ah diiqadda dabiiciga ee heerka labaad: dib u eegis iyo naqdin. J Saamaynta. 2011; 130: 343-357. Eeg aragti
  88. Leu-Semenescu, S., Arnulf, I., Decaix, C., Moussa, F., Clot, F., Boniol, C., Touitou, Y., Levy, R., Vidailhet, M., iyo Roze, E. Cawaaqibta hurdada iyo laxanka ee hidaha hidaha serotonin. Hurdo 3-1-2010; 33: 307-314. Eeg aragti
  89. Freedman RR. Daaweynta bilaha kuleylka ee dhalmo dayska oo leh 5-hydroxytryptophan. Maturitas 2010; 65: 383-5. Eeg aragti
  90. Toddobaadyada, B. S. Qaababaynta kaabisyada cuntada iyo soosaarka dhirta ee nasashada iyo ficil-xumada: Relarian. Monit Sayniska. 2009; 15: RA256-RA262. Eeg aragti
  91. Rondanelli M, Klersy C, Iadarola P, et al. Baaxad-darrada iyo astaamaha amino-acid ee dumarka cayilan ka dib daaweyn cusub iyadoo la adeegsanayo warshad dabiici ah oo laga soosaaray buufin sublingual ah. Int J Obes (Lond) 2009; 33: 1174-1182. Eeg aragti
  92. Maissen CP, Ludin HP. [Isbarbardhiga saameynta 5-hydroxytryptophan iyo propranolol ee daaweynta udhaxeysa madax xanuunka dhanjafka]. Schweiz Med Wochenschr 1991; 121: 1585-90. Eeg aragti
  93. Shell W, Bullias D, Charuvastra E, et al. Tijaabinta, xakamaynta xakamaynta xakamaynta ee diyaarinta amino acid ee waqtiga iyo tayada hurdada. Am J Ther 2010; 17: 133-9. Eeg aragti
  94. Trujillo-Martin, M. M., Serrano-Aguilar, P., Monton-Alvarez, F., iyo Carrillo-Fumero, R. Waxtarka iyo badbaadada daaweynta daaweynta ataxias xumaata: dib u eegis nidaamsan. Khilaafka Mov. 6-15-2009; 24: 1111-1124. Eeg aragti
  95. Rothman, R. B. Daaweynta buurnaanta iyadoo la socota "isku-darka" farmasotherapy. Am J Ther 2010; 17: 596-603. Eeg aragti
  96. Chae, HS, Kang, OH, Choi, JG, Oh, YC, Lee, YS, Jang, HJ, Kim, JH, Park, H., Jung, KY, Sohn, DH, iyo Kwon, DY 5-hydroxytryptophan ayaa wax ka qabata mitogen-activated protein kinase extracellular-signal nidaaminaya marinka borotiinka kinase si loogu beddelo cyclooxygenase-2 iyo muujinta nitric oxide synthase ee unugyada RAW 264.7. Biol Pharm Bull 2009; 32: 553-557. Eeg aragti
  97. Hendricks, E. J., Rothman, R. B., iyo Greenway, F. L. Sidee takhasusayaasha cayilku ugu takhasusay bukaanku u isticmaalaan daawooyinka lagu daaweeyo buurnida. Cayilnaanta. (Silver.Spring) 2009; 17: 1730-1735. Eeg aragti
  98. Longo, N. Cilladaha dheef-shiid kiimikaadka biopterin. J Dhaxalka. Met Dis Dis 2009; 32: 333-342. Eeg aragti
  99. Pons, R. Nooca muuqaalka guud ee cudurada cudurada neerfaha gudbiya iyo cudurka Parkinsonism ee caruurta. J Dhaxalka. Met Dis Dis 2009; 32: 321-332. Eeg aragti
  100. Schaefer, M., Winterer, J., Sarkar, R., Uebelhack, R., Franke, L., Heinz, A., iyo Friebe, A. Seddex xaaladood oo tijaabo ah oo tijaabo ah oo lagu guuleystay ama loo daaweeyo cagaarshowga C iyo IFNalpha -lacaawdo niyadda oo isku xidhan. Cilmu-nafsiga 2008; 49: 442-446. Eeg aragti
  101. Jacobsen, JP, Nielsen, EO, Hummel, R., Redrobe, JP, Mirza, N., iyo Weikop, P. Dareenka jiirka NMRI ee xulashada serotonin reuptake inhibitors ee tijaabada ganaaxa dabada ayaa lagu rogi karaa iyadoo lala wadaago 5 -hydroxytryptophan. Cilmu-nafsiga (Berl) 2008; 199: 137-150. Eeg aragti
  102. Liu, K. M., Liu, T. T., Lee, N. C., Cheng, L. Y., Hsiao, K. J., iyo Niu, D. M. La socoshada muddada dheer ee bukaanada Shiineeska ah ee Shiineeska ah ee horay loogu daaweeyay yaraanshaha 6-pyruvoyl-tetrahydropterin. Qalabka Neurol. 2008; 65: 387-392. Eeg aragti
  103. Horvath, GA, Stockler-Ipsiroglu, SG, Salvarinova-Zivkovic, R., Lillquist, YP, Connolly, M., Hyland, K., Blau, N., Rupar, T., iyo Waters, PJ Autosomal recessive GTP cyclohydrolase I yaraanta iyada oo aan lahayn hyperphenylalaninemia: caddaynta istiraatiijiyad isku mid ah oo udhaxeysa qaababka xukunka iyo recessive. Mol.Getet. Metab 2008; 94: 127-131. Eeg aragti
  104. Morrow, J. D., Vikraman, S., Imeri, L., iyo Opp, M. R. Saameynta firfircoonaanta serotonergic ee 5-hydroxytryptophan ee hurdada iyo heerkulka jirka ee C57BL / 6J iyo jiirka liita ee interleukin-6 ayaa ah qiyaasta iyo waqtiga la xiriira. Seexo 1-1-2008; 31: 21-33. Eeg aragti
  105. Meolie, AL, Rosen, C., Kristo, D., Kohrman, M., Gooneratne, N., Aguillard, RN, Fayle, R., Troell, R., Townsend, D., Claman, D., Hoban, T., iyo Mahowald, M. Daaweynta aan afka laga qorin ee hurdo la'aanta: qiimeynta alaabooyinka leh caddayn xadidan. J Clin. Hurdada Med 4-15-2005; 1: 173-187. Eeg aragti
  106. Cangiano C, Ceci F, Cairella M, iyo al. Saamaynta 5-hydroxytryptophan ee ku saabsan dabeecadda cunista iyo u hoggaansamida rijeetooyinka loo qoro ee maadooyinka dadka waaweyn ee buuran. Adv Exp Med Biol 1991; 294: 591-3. Eeg aragti
  107. Petre-Quadens, O. iyo De Lee, C. 5-Hydroxytryptophan oo ay seexdaan cilladda Down’s syndrome. J Neurol Sci 1975; 26: 443-453. Eeg aragti
  108. Lesch, K. P., Hoh, A., Disselkamp-Tietze, J., Wiesmann, M., Osterheider, M., iyo Schulte, H. M. 5-Hydroxytryptamine1A jawaab celin xasaasi ah oo ku saabsan khalkhalka qasabka ah. Isbarbardhiga bukaanada iyo kontaroolada. Dhakhtarka maskaxda ee maskaxda 1991; 48: 540-547. Eeg aragti
  109. Halladay, AK, Wagner, GC, Sekowski, A., Rothman, RB, Baumann, MH, iyo Fisher, H. Wax ka beddelka isticmaalka aalkolada, suuxdinta ka-noqoshada, iyo gudbinta monoamine ee jiirka lagu daaweeyay phentermine iyo 5-hydroxy-L-tryptophan . Dhexdhexaad 2006; 59: 277-289. Eeg aragti
  110. Curcio, J. J., Kim, L. S., Wollner, D., iyo Pockaj, B. A. Awoodda 5-hydryoxytryptophan ee dhimista flash hot: mala awaal. Beddelka 'Med Med' 2005; 10: 216-221. Eeg aragti
  111. Victor, S. iyo Ryan, S. W. Dawooyinka looga hortago madax xanuunka dhanjafka ee carruurta. Macluumaadka Cochrane. Syst. Rev. 2003;: CD002761. Eeg aragti
  112. George DT, Lindquist T, Rawlings RR, et al. Dayactirka farmashiyaha ee ka fogaanshaha bukaanka qaba khamriga: waxtar ma leh 5-hydroxytryptophan ama levodopa. Clin Pharmacol Ther 1992; 52: 553-60. Eeg aragti
  113. Shaw, K., Turner, J., iyo Del Mar, C. Tryptophan iyo 5-hydroxytryptophan niyad jab. Macluumaadka Cochrane. Syst Rev 2002;: CD003198. Eeg aragti
  114. Ciaranello, R. D., Anders, T. F., Barchas, J. D., Berger, P. A., iyo Cann, H. M. Isticmaalka 5-hydroxytryptophan ee cunug qaba cudurka Lesch-Nyhan syndrome. Maskaxda Carruurta Hum Dev 1976; 7: 127-133. Eeg aragti
  115. Anderson, L. T., Herrmann, L., iyo Dancis, J. Saamaynta L-5-hydroxytryptophan ee is-u-dhimista cudurka Lesch-Nyhan: warbixin taban. Neuropadiatrie. 1976; 7: 439-442. Eeg aragti
  116. Growdon, J. H., Young, R. R., iyo Shahani, B. T. L-5-hydroxytryptophan ee lagu daaweynayo dhowr noocyo kala duwan oo myoclonus caan ku yahay. Neerfaha 1976; 26: 1135-1140. Eeg aragti
  117. Takahashi S, Kondo H, Kato N. Saameynta l-5-hydroxytryptophan ee ku saabsan dheef-shiid kiimikaadka maskaxda ee monoamine iyo qiimeynta saameynta caafimaad ee bukaannada niyadjabsan. J Cilmi-nafsiga Res 1975; 12: 177-87. Eeg aragti
  118. Preshaw RM, Leavitt D, Hoag G. Cuntada dheeriga ah ee 5-hydroxytryptophan iyo kaadida 5-hydroxyindole acetic acid. CMAJ 2008; 178: 993. Eeg aragti
  119. Byerley WF, Judd LL, Reimherr FW, Grosser BI. 5-Hydroxytryptophan: dib u eegis ku saabsan waxtarka antidepressant iyo saameynta xun. J Clin Psychopharmacol 1987; 7: 127-37 .. Eeg duluc.
  120. Shaw K, Turner J, Del Mar C. Tryptophan iyo 5-hydroxytryptophan niyad jab. Macluumaadka Cochrane Syst Rev 2002;: CD003198. Eeg aragti
  121. Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V. Daraasad laba-indhoole ah oo 5-hydroxytryptophan ah oo ku wajahan placebo ee daaweynta fibromyalgia syndrome. J Int Med Res 1990; 18: 201-9. Eeg aragti
  122. Johnson KL, Klarskov K, Benson LM, iyo al. Joogitaanka ugu sarreysa X iyo xeryahooda la xiriira: wasakheynta la soo sheegay ee la xiriirta kiis la xiriira 5-hydroxy-L-tryptophan oo la xiriira eosinophilia-myalgia syndrome. J Rheumatol 1999; 26: 2714-7. Eeg aragti
  123. Singhal AB, Caviness VS, Begleiter AF, iyo al. Qalitaanka maskaxda iyo istaroogga ka dib isticmaalka dawooyinka serotonergic. Neerfaha 2002; 58: 130-3. Eeg aragti
  124. U. S. Maamulka Cuntada iyo Dawada, Xarunta Badbaadada Cuntada iyo Nafaqada La Adeegsaday, Xafiiska Badeecooyinka nafaqada, Calaamadeynta, iyo Cuntooyinka lagu daro. Warqad Macluumaad ku saabsan L-Tryptophan iyo 5-hydroxy-L-tryptophan, Febraayo 2001.
  125. Nardini M, De Stefano R, Iannuccelli M, iyo al. Daaweynta niyad-jabka L-5-hydroxytryptophan oo ay weheliso chlorimipramine, daraasad laba-indhoole ah. Int J Clin Pharmacol Qaraarka 1983; 3: 239-50. Eeg aragti
  126. Ribeiro CA. L-5-Hydroxytryptophan oo ku jira kahortaga madax xanuunka noocan ah ee daba-dheeraada: daraasad laba-indhoole ah, kala-sooc ah, placebo-kontorool ah. Madax xanuun 2000; 40: 451-6. Eeg aragti
  127. Poldinger W, Calanchini B, Schwarz W. Habka waxqabadka u leh cabirka: serotonin yaraanta oo ah bartilmaameedka cilladda marka la barbardhigo 5-hydroxytryptophan iyo fluvoxamine. Cilmu-nafsiga 1991; 24: 53-81. Eeg aragti
  128. Sternberg EM, Van Woert MH, Young SN, iyo al. Horumarinta cudurka sida scleroderma u eg inta lagu jiro daweynta L-5-hydroxytryptophan iyo carbidopa. N Engl J Med 1980; 303: 782-7. Eeg aragti
  129. Maamulka Cuntada iyo Dawooyinka ee Mareykanka. Wasakhda ayaa lagu xaqiijiyay dheecaanka cuntada 5-hydroxy-L-tryptophan. Warqadda Hadalka ee FDA, Ogosto 31, 1998; T98-48.
  130. Meyer JS, Welch KM, Deshmukh VD, iyo al. Neurotransmitter preursor amino acids oo lagu daaweeyo waallida infakshanno fara badan iyo cudurka Alzheimer. J Amer Geriat Soc 1977; 25: 289-98. Eeg aragti
  131. Trouillas P, Brudon F, Adeleine P. Hagaajinta cerebellar ataxia oo leh foomka levorotatory ee 5-hydroxytryptophan: daraasad laba-indhoole ah oo leh xog uruurin xog leh. Qalabka Neurol 1988; 45: 1217-22. Eeg aragti
  132. Kahn RS, Westenberg HG. L-5-hydroxytryptophan ee daaweynta xanuunka walwalka. J Wuxuu saameyn ku yeeshay Dhibaatada 1985; 8: 197-200. Eeg aragti
  133. Cangiano C, Ceci F, Cancino A, et al. Dhaqanka cunida iyo u hogaansanaanta rijeetooyinka loo qoro ee maadooyinka qaangaarka ah ee cayilan ee lagu daaweeyo 5-hydroxytryptophan. Am J Clin Nutr 1992; 56: 863-7. Eeg aragti
  134. Sarzi Puttini P, Caruso I. Cudurka fibromyalgia ee aasaasiga ah iyo 5-hydroxy-L-tryptophan: daraasad furan oo 90-maalmood ah. J Int Med Res 1992; 20: 182-9. Eeg aragti
  135. Nakajima T, Kudo Y, Kaneko Z. Qiimaynta caafimaad ee 5-hydroxy-L-tryptophan oo ah daroogada lidka diiqadda. Cudurka maskaxda ee Folia Neurol Jpn 1978; 32: 223-30. Eeg aragti
  136. Michelson D, Bogga SW, Casey R, iyo al. Cudurka 'eosinophilia-myalgia syndrome' ee la xiriira cillad la xiriirta soo-gaadhista L-5-hydroxytryptophan. J Rheumatol 1994; 21: 2261-5. Eeg aragti
  137. Birdsall TC. 5-Hydroxytryptophan: Horudhac Caafimaad oo Waxtar Leh Serotonin. Beddelka Med Rev 1998; 3: 271-80. Eeg aragti
Markii ugu dambeysay ee dib loo eegay - 12/29/2020

Si Soo Xiiso U Leh

3 Talooyin si loo fududeeyo Cunto kasta oo Cuntada Kraft ah
Hab-Nololeed

3 Talooyin si loo fududeeyo Cunto kasta oo Cuntada Kraft ah

Way fududahay in la dhex galo raa hin cunto. Laga oo bilaabo cuni ta i la badarka quraacda ilaa had iyo jeer xirxirida i la anduuqii qadada ama ameynta i ku beddelkii ca hada guriga, qof walba wuxuu i...
Barnaamijyada Baraha Bulshada oo aad u badan ayaa Kordhiya Khatartaada Murugada iyo Walwalka
Hab-Nololeed

Barnaamijyada Baraha Bulshada oo aad u badan ayaa Kordhiya Khatartaada Murugada iyo Walwalka

Ma jirto wax la inkiri karo in baraha bul hada ay aamayn weyn ku leedahay nolo heena, laakiin miyuu uurtogal yahay inay idoo kale aamayn ku yeelanay o caafimaadka dhimirka? In ka ta oo lala xiriiriyay...